Prevalence of Cardiac Manifestations of COVID-19 at a Tertiary Centre in Western Rajasthan
Authors/Creators
- 1. Associate Professor, Department of Cardiology, Dr SN Medical College, Jodhpur, Rajasthan
- 2. Senior Resident, Department of Cardiology, Dr SN Medical College, Jodhpur, Rajasthan
- 3. Associate Professor& Head, Department of Cardiology, Dr SN Medical College, Jodhpur Rajasthan
- 4. Assistant Professor, Department of Cardiology, Dr SN Medical College, Jodhpur, Rajasthan
Description
Introduction: The coronavirus disease 2019 (COVID-19) pandemic has brought unprecedented challenges to global healthcare systems, with the respiratory system being predominantly affected. However, emerging evidence suggests that COVID-19 can also lead to various cardiovascular complications. This retrospective study aims to investigate the prevalence of cardiac manifestations in COVID-19 patients and its association with disease severity. Methods: We conducted a retrospective analysis of medical records from 350 patients admitted with COVID-19 infection at a tertiary care hospital between June 2020 and July 2022. Patients were categorized into severe and non-severe groups based on clinical, lab parameters. Various cardiac manifestations, including heart failure, arrhythmias, myocarditis, acute coronary syndrome (ACS), and pulmonary embolism, were evaluated. Results: Our findings revealed a clear correlation between the severity of COVID-19 and the prevalence of cardiovascular complications. Heart failure was observed in 7.4% of patients, with a significantly higher incidence rate in the severe COVID-19 group (10.9% versus 2.7% in non-severe group, p < 0.01). Similarly, the overall incidence of cardiac arrhythmias was 7.1%, with a higher prevalence in the severe COVID-19 group (10.5% versus 2.7% in non-severe group, p < 0.01). Myocarditis and ACS were reported in 6.6% and 10.3% of patients, respectively, with significantly higher rates in severe COVID-19 cases (p < 0.01). Additionally, pulmonary embolism was identified in 1.4% of patients, predominantly in the severe COVID-19 group (p < 0.01). Conclusion: Our study provides valuable insights into the diverse cardiac complications associated with COVID-19. The findings underscore the importance of vigilance among clinicians to recognize and manage these manifestations, particularly in severe cases. By understanding the impact of COVID-19 on cardiovascular health, healthcare providers can take proactive measures to optimize patient outcomes. Further research is needed to explore the underlying mechanisms and develop targeted interventions for these cardiac complications.
Abstract (English)
Introduction: The coronavirus disease 2019 (COVID-19) pandemic has brought unprecedented challenges to global healthcare systems, with the respiratory system being predominantly affected. However, emerging evidence suggests that COVID-19 can also lead to various cardiovascular complications. This retrospective study aims to investigate the prevalence of cardiac manifestations in COVID-19 patients and its association with disease severity. Methods: We conducted a retrospective analysis of medical records from 350 patients admitted with COVID-19 infection at a tertiary care hospital between June 2020 and July 2022. Patients were categorized into severe and non-severe groups based on clinical, lab parameters. Various cardiac manifestations, including heart failure, arrhythmias, myocarditis, acute coronary syndrome (ACS), and pulmonary embolism, were evaluated. Results: Our findings revealed a clear correlation between the severity of COVID-19 and the prevalence of cardiovascular complications. Heart failure was observed in 7.4% of patients, with a significantly higher incidence rate in the severe COVID-19 group (10.9% versus 2.7% in non-severe group, p < 0.01). Similarly, the overall incidence of cardiac arrhythmias was 7.1%, with a higher prevalence in the severe COVID-19 group (10.5% versus 2.7% in non-severe group, p < 0.01). Myocarditis and ACS were reported in 6.6% and 10.3% of patients, respectively, with significantly higher rates in severe COVID-19 cases (p < 0.01). Additionally, pulmonary embolism was identified in 1.4% of patients, predominantly in the severe COVID-19 group (p < 0.01). Conclusion: Our study provides valuable insights into the diverse cardiac complications associated with COVID-19. The findings underscore the importance of vigilance among clinicians to recognize and manage these manifestations, particularly in severe cases. By understanding the impact of COVID-19 on cardiovascular health, healthcare providers can take proactive measures to optimize patient outcomes. Further research is needed to explore the underlying mechanisms and develop targeted interventions for these cardiac complications.
Files
IJPCR,Vol15,Issue8,Article99.pdf
Files
(355.5 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:c7f2ddbd9aa5e83801139a465500ecf8
|
355.5 kB | Preview Download |
Additional details
Dates
- Accepted
-
2023-05-25
Software
- Repository URL
- https://impactfactor.org/PDF/IJPCR/15/IJPCR,Vol15,Issue8,Article99.pdf
- Development Status
- Active
References
- 1. Jayaweera M, Perera H, Gunawardana B, Manatunge J. Transmission of COVID-19 virus by droplets and aerosols: A critical review on the unresolved dichotomy. Environmental research. 2020 Sep 1;188:109819. 2. Beyerstedt S, Casaro EB, Rangel ÉB. COVID19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARSCoV-2 infection. European journal of clinical microbiology & infectious diseases. 2021 May;40:905-19. 3. Kaye AD, Spence AL, Mayerle M, Sardana N, Clay CM, Eng MR, Luedi MM, Turpin MA, Urman RD, Cornett EM. Impact of COVID-19 infection on the cardiovascular system: An evidence-based analysis of risk factors and outcomes. Best Practice & Research Clinical Anaesthesiology. 2021 Oct 1;35(3):437-48. 4. Gadanec LK, McSweeney KR, Qaradakhi T, Ali B, Zulli A, Apostolopoulos V. Can SARSCoV-2 virus use multiple receptors to enter host cells?. International journal of molecular sciences. 2021 Jan 20;22(3):992. 5. Farshidfar F, Koleini N, Ardehali H. Cardiovascular complications of COVID-19. JCI insight. 2021 Jul 7;6(13). 6. Chen T, Wu DI, Chen H, Yan W, Yang D, Chen G, Ma K, Xu D, Yu H, Wang H, Wang T. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. bmj. 2020 Mar 26;368. 7. Liu K, Fang YY, Deng Y, et al. Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province. Chin Med J. 2020;133:1025‐1031. 8. Deng Q, Hu B, Zhang Y, et al. Suspected myocardial injury in patients with COVID‐19: evidence from front‐line clinical observation in Wuhan, China. Int J Cardiol. 2020;311:116‐121. 9. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506. 10. Rupak Desai et al. Prevalence of Pulmonary Embolism in COVID-19: a Pooled Analysis SN Compr Clin Med. 2020; 2(12): 2722–2725.